At a glance
ClinicalIndex Comparison RecordN/ACompleted· 89 enrolled
Drug / intervention
senofilcon A toric +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Multi-Center, Subject Masked, Randomized, Two Week Crossover Design, Investigation of the Acuvue Cypress Toric Silicone Hydrogel Lens Compared to the Bausch & Lomb SofLens66® Toric Hydrophilic Lens
In Brief
A clinical study evaluating senofilcon A toric and alphafilcon A toric for Ametropia. Completed, enrolled 89 participants across 7 sites.
Detailed Summary
The purpose of this study is to evaluate and compare the clinical performance of two toric contact lenses amongst 110 subjects, 2-week, single masked (subject), daily wear, randomized, bilateral, crossover study; 4 weeks duration. Hypotheses include equal or better performance of the test lens over the control lenses for comfort, vision, and toric fit characteristics as well as corneal integrity
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAmetropia
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartFeb 2008
First PostedMar 2008
Primary CompletionJun 2008
TodayJul 2026
First PostedMar 20, 2008
Enrollment StartFeb 1, 2008
Primary CompletionJun 1, 2008
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 18.3 years ago
Interventions
senofilcon A toricdevice
silicone hydrogel toric lens, 2 wk replacement, daily wear
alphafilcon A toricdevice
hydrogel toric lens, 2 wk replacement, daily wear